InvestorsHub Logo
Post# of 4988334
Next 10
Followers 32
Posts 5244
Boards Moderated 0
Alias Born 10/07/2009

Re: None

Sunday, 05/27/2018 12:43:08 AM

Sunday, May 27, 2018 12:43:08 AM

Post# of 4988334
OBMP gets the Institutional Review Board and Scientific Review Committee at the Dana-Farber Cancer Institute approved the clinical trial of ProscaVax™, the Company’s lead immunotherapy product from its platform. so do some DD this could just become MEGA should get more interesting as we await the news.


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.